Evidence map›Paper›PMID 21777704›Full record

ReviewBiochimica et biophysica acta2012

Proteases involved in cartilage matrix degradation in osteoarthritis.

Linda Troeberg, Hideaki Nagase

Abstract readReview
In one paragraph

Review in Biochimica et biophysica acta, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 300 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
300citing papers in PubMed, 2 pooled it
9.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

300 citing papers in PubMed, 2 syntheses or guidelines pooled it, 562 citations in OpenAlex.

  1. Pooled it
  2. Tetracycline use in treating osteoarthritis: a systematic review.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2021
    Pooled it
  3. Trial
  4. Trial
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Review

240 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 2 countries.

Linda TroebergThe Kennedy Institute of Rheumatology Division, Imperial College London, London, UK. linda.troeberg@kennedy.ox.ax.uk
Hideaki Nagase
Imperial College London · GB

Funding

TIMP Engineering and Application to ArthritisR01AR040994 · NIAMS · UNIVERSITY OF KANSAS MEDICAL CENTER · PI BREW, KEITH · 1991 to 2013
$4.8M
Arthritis Research UK 19466NIAMS NIH HHS AR40994NIAMS NIH HHS R01 AR040994Versus Arthritis 19466
6 · The paper itself

Abstract

Osteoarthritis is a common joint disease for which there are currently no disease-modifying drugs available. Degradation of the cartilage extracellular matrix is a central feature of the disease and is widely thought to be mediated by proteinases that degrade structural components of the matrix, primarily aggrecan and collagen. Studies on transgenic mice have confirmed the central role of Adamalysin with Thrombospondin Motifs 5 (ADAMTS-5) in aggrecan degradation, and the collagenolytic matrix metalloproteinase MMP-13 in collagen degradation. This review discusses recent advances in current understanding of the mechanisms regulating expression of these key enzymes, as well as reviewing the roles of other proteinases in cartilage destruction. This article is part of a Special Issue entitled: Proteolysis 50 years after the discovery of lysosome.

Indexed as

ProteolysisADAM ProteinsAnimalsCartilageCollagenasesExtracellular MatrixGene Expression Regulation, EnzymologicHumansMatrix MetalloproteinasesMiceModels, BiologicalOsteoarthritisPeptide HydrolasesADAM ProteinsCollagenasesMatrix MetalloproteinasesPeptide Hydrolases

Identifiers

PMID21777704
PMCPMC3219800
OpenAlexW2010404343

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.